Literature DB >> 17545556

Novel deletions of 14q11.2 associated with developmental delay, cognitive impairment and similar minor anomalies in three children.

Farah Zahir1, Helen V Firth, Agnes Baross, Allen D Delaney, Patrice Eydoux, William T Gibson, Sylvie Langlois, Howard Martin, Lionel Willatt, Marco A Marra, Jan M Friedman.   

Abstract

METHODS AND
RESULTS: We identified de novo submicroscopic chromosome 14q11.2 deletions in two children with idiopathic developmental delay and cognitive impairment. Vancouver patient 5566 has a approximately 200 kb deletion and Vancouver patient 8326 has a approximately 1.6 Mb deletion. The Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources (DECIPHER) revealed a third patient with idiopathic developmental delay and cognitive impairment, DECIPHER patient 126, who has a approximately 1.1 Mb deletion of 14q11.2. The deletion of patient 5566 overlaps that of patient 126 and both of these deletions lie entirely within that of patient 8326. All three children have similar dysmorphic features, including widely-spaced eyes, short nose with flat nasal bridge, long philtrum, prominent Cupid's bow of the upper lip, full lower lip and similar auricular anomalies.
CONCLUSION: The minimal common deletion region on chromosome 14q11.2 is only approximately 35 kb (from 20.897 to 20.932, University of California at Santa Cruz (UCSC) Genome Browser; build hg18, March 2006) and includes only two genes, SUPT16H and CHD8, which are good candidate genes for the phenotypes. The non-recurrent breakpoints of these patients, the presence of normal copy number variants in the region and the local genomic structure support the notion that this region has reduced stability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545556      PMCID: PMC2597953          DOI: 10.1136/jmg.2007.050823

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  28 in total

1.  Abnormal myelination in a patient with deletion 14q11.2q13.1.

Authors:  G P Ramelli; L Remonda; K O Lövblad; H Hirsiger; H Moser
Journal:  Pediatr Neurol       Date:  2000-08       Impact factor: 3.372

2.  FACT facilitates transcription-dependent nucleosome alteration.

Authors:  Rimma Belotserkovskaya; Sangtaek Oh; Vladimir A Bondarenko; George Orphanides; Vasily M Studitsky; Danny Reinberg
Journal:  Science       Date:  2003-08-22       Impact factor: 47.728

3.  De novo interstitial proximal deletion of 14q and prenatal diagnosis of holoprosencephaly.

Authors:  H Bruyere; B Favre; S Douvier; A Nivelon-Chevalier; F Mugneret
Journal:  Prenat Diagn       Date:  1996-11       Impact factor: 3.050

4.  Another patient with a deletion 14q11.2q13.

Authors:  L Govaerts; J Toorman; M V Blij-Philipsen; D Smeets
Journal:  Ann Genet       Date:  1996

5.  First case of deletion 14q11.2q13: clinical phenotype.

Authors:  P Grammatico; S de Sanctis; C di Rosa; F Cupilari; G del Porto
Journal:  Ann Genet       Date:  1994

6.  The Paf1 complex physically and functionally associates with transcription elongation factors in vivo.

Authors:  Sharon L Squazzo; Patrick J Costa; Derek L Lindstrom; Kathryn E Kumer; Rajna Simic; Jennifer L Jennings; Andrew J Link; Karen M Arndt; Grant A Hartzog
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

7.  Transcription elongation factors repress transcription initiation from cryptic sites.

Authors:  Craig D Kaplan; Lisa Laprade; Fred Winston
Journal:  Science       Date:  2003-08-22       Impact factor: 47.728

8.  De novo proximal interstitial deletions of 14q: cytogenetic and molecular investigations.

Authors:  S K Shapira; K L Anderson; A Orr-Urtregar; W J Craigen; J R Lupski; L G Shaffer
Journal:  Am J Med Genet       Date:  1994-08-01

9.  The FACT complex travels with elongating RNA polymerase II and is important for the fidelity of transcriptional initiation in vivo.

Authors:  Paul B Mason; Kevin Struhl
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Corpus callosum agenesis, multiple cysts, skin defects, and subtle ocular abnormalities with a de novo mutation [45,XX,der(5), t(5;;14) (pter;q11.2)].

Authors:  R Zannolli; R Mostardini; L Pucci; L Sorrentino; M Biagioli; R Perotti; M Guarna; T Hadjistilianou; G Zerega; M Pierluigi; B Franco; A D'Ambrosio; G Morgese
Journal:  Am J Med Genet       Date:  2001-07-22
View more
  26 in total

Review 1.  From the genetic architecture to synaptic plasticity in autism spectrum disorder.

Authors:  Thomas Bourgeron
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

2.  Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits.

Authors:  Randall J Platt; Yang Zhou; Ian M Slaymaker; Ashwin S Shetty; Niels R Weisbach; Jin-Ah Kim; Jitendra Sharma; Mitul Desai; Sabina Sood; Hannah R Kempton; Gerald R Crabtree; Guoping Feng; Feng Zhang
Journal:  Cell Rep       Date:  2017-04-11       Impact factor: 9.423

Review 3.  Structure and mechanisms of lysine methylation recognition by the chromodomain in gene transcription.

Authors:  Kyoko L Yap; Ming-Ming Zhou
Journal:  Biochemistry       Date:  2011-02-23       Impact factor: 3.162

4.  16p11.2 microdeletion imparts transcriptional alterations in human iPSC-derived models of early neural development.

Authors:  Julien G Roth; Kristin L Muench; Aditya Asokan; Victoria M Mallett; Hui Gai; Yogendra Verma; Stephen Weber; Carol Charlton; Jonas L Fowler; Kyle M Loh; Ricardo E Dolmetsch; Theo D Palmer
Journal:  Elife       Date:  2020-11-10       Impact factor: 8.140

5.  Duplications of FOXG1 in 14q12 are associated with developmental epilepsy, mental retardation, and severe speech impairment.

Authors:  Nicola Brunetti-Pierri; Alex R Paciorkowski; Roberto Ciccone; Erika Della Mina; Maria Clara Bonaglia; Renato Borgatti; Christian P Schaaf; V Reid Sutton; Zhilian Xia; Naftha Jelluma; Claudia Ruivenkamp; Mary Bertrand; Thomy J L de Ravel; Parul Jayakar; Serena Belli; Katia Rocchetti; Chiara Pantaleoni; Stefano D'Arrigo; Jeff Hughes; Sau Wai Cheung; Orsetta Zuffardi; Pawel Stankiewicz
Journal:  Eur J Hum Genet       Date:  2010-08-25       Impact factor: 4.246

6.  CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors.

Authors:  Aarathi Sugathan; Marta Biagioli; Christelle Golzio; Serkan Erdin; Ian Blumenthal; Poornima Manavalan; Ashok Ragavendran; Harrison Brand; Diane Lucente; Judith Miles; Steven D Sheridan; Alexei Stortchevoi; Manolis Kellis; Stephen J Haggarty; Nicholas Katsanis; James F Gusella; Michael E Talkowski
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-07       Impact factor: 11.205

7.  Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.

Authors:  Sahrunizam Kasah; Christopher Oddy; M Albert Basson
Journal:  J Anat       Date:  2018-10-02       Impact factor: 2.610

Review 8.  DECIPHER: web-based, community resource for clinical interpretation of rare variants in developmental disorders.

Authors:  Ganesh J Swaminathan; Eugene Bragin; Eleni A Chatzimichali; Manuel Corpas; A Paul Bevan; Caroline F Wright; Nigel P Carter; Matthew E Hurles; Helen V Firth
Journal:  Hum Mol Genet       Date:  2012-09-08       Impact factor: 6.150

9.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources.

Authors:  Helen V Firth; Shola M Richards; A Paul Bevan; Stephen Clayton; Manuel Corpas; Diana Rajan; Steven Van Vooren; Yves Moreau; Roger M Pettett; Nigel P Carter
Journal:  Am J Hum Genet       Date:  2009-04-02       Impact factor: 11.025

10.  Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior.

Authors:  Yan Li; Anqi Yin; Xin Sun; Ming Zhang; Jianfang Zhang; Ping Wang; Rougang Xie; Wen Li; Ze Fan; Yuanyuan Zhu; Han Wang; Hailong Dong; Shengxi Wu; Lize Xiong
Journal:  J Clin Invest       Date:  2017-10-23       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.